GlaxoSmithKline Biologicals S.A.;Glaxo Group Limited
发明人:
BROWN, James,METTENS, Pascal,MURPHY, Dennis
申请号：
LT09781058
公开号：
LT2315597T
申请日:
2009.07.24
申请国别(地区):
LT
年份:
2018
代理人:
摘要：
The present invention is directed to a polypeptide which comprises: (i) an Rv1753c protein sequence； (ii) a variant of an Rv1753c protein sequence； or (iii) an immunogenic fragment of an Rv1753c protein sequence. In other aspects the invention is directed to associated polynucleotides, fusion proteins and methods for the treatment or prevention of tuberculosis.
